Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cellsXiaolong Wei, Mazhar Adli, Harun Öztürk et al.|Proceedings of the National Academy of Sciences|2020Cited by 113